Clinical characteristics and survival outcomes in patients with pulmonary sarcomatoid carcinoma: a multicenter retrospective study
PSC exhibits high KRAS and EGFR mutation rates, and spindle cell carcinoma has a worse prognosis. Immunotherapy shows potential as a treatment for advanced PSC.
Authors
- Zhefeng Liu (ORCID: https://orcid.org/0000-0002-6160-7194)
- Tao Li (ORCID: https://orcid.org/0000-0002-5074-0184)
- Zhijuan Du
- Yuhui Qin
- Hu Yi (ORCID: https://orcid.org/0000-0003-0844-2498)
- Jie Gao (ORCID: https://orcid.org/0009-0006-6729-8114)
- Siyuan Chen (ORCID: https://orcid.org/0009-0002-2593-198X)
- Yahui Lv
- Xiangyu Du
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Chinese PLA General Hospital (CN)
- PLA Academy of Military Science (CN)
Publication Details
- Journal
- Clinical & Translational Oncology
- Published
- 2024-12-25
- DOI
- https://doi.org/10.1007/s12094-024-03823-8
- Citations
- 1
- Primary Topic
- Metastasis and carcinoma case studies
- Type
- article
- Field-Weighted Citation Impact
- 0.42